Join Now

Author Archives: admin

Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd

LONDON and SALT LAKE CITY, February 9, 2024 – Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on February 8, 2024 the Centers for Medicare and Medicaid Services (“CMS”) published a draft Local Coverage Determination (“LCD”) for the Company’s KidneyIntelX and kidneyintelX.dkd testing. The draft LCD can be accessed at https://www.cms.gov/medicare-coverage-database/. The established Medicare price […]

Posted in BioUtah News | Comments Off on Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd

Utah Legislative Recap, Feb. 9, 2024

Funding Requests   Life Sciences Initiative – Senator Ann Millner The original initiative requested the legislature provide $7.125M of ongoing funding to higher education in Utah to support the workforce needs of Utah’s Life Sciences industry.  BioUtah has worked closely with Talent Ready Utah, colleges and universities in the state, and other stakeholders to create […]

Posted in BioUtah News | Comments Off on Utah Legislative Recap, Feb. 9, 2024

2024 Life Sciences Day on the Hill Recap

Utah’s vibrant life sciences industry was on full display February 7 as part of BioUtah’s “Life Sciences Day on the Hill”. The event, a collarboration with the Governor’s Office of Economic Opportunity, (GOEO) was held at the state capitol. 29 companies exhibited their innovative technologies in the capitol rotunda, which provided legislators the opportunity to […]

Posted in BioUtah News | Comments Off on 2024 Life Sciences Day on the Hill Recap

Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics

Funds will support the advancement of lead programs in Phase II clinical trials, evaluating HT-6184, Halia’s first-in-class NLRP3/NEK7 inflammasome inhibitor, and advancing additional programs into the clinic. LEHI, Utah, Jan. 31, 2024 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the completion […]

Posted in Policy News | Comments Off on Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics

Halia Therapeutics Dosed its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for the Treatment of Lower-Risk Myelodysplastic Syndromes

LEHI, Utah /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the dosing of the first patient in Phase 2a clinical trial evaluating its lead candidate, HT-6184, for the treatment of lower-risk myelodysplastic syndromes (LR-MDS). HT-6184 is a selective and orally bioavailable first-in-class […]

Posted in BioUtah News | Comments Off on Halia Therapeutics Dosed its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for the Treatment of Lower-Risk Myelodysplastic Syndromes

RxCell Announces $4.6M Investment from DMR Global Venture and Regenosis, Plans for Second Raise of $15M for IND Testing in Q4 2023

SINGAPORE–(BUSINESS WIRE)–RxCell, a pioneering biotech company focusing on cellular therapeutics for age-related diseases, today proudly announces a $4,600,000 investment commitment from DMR Global Venture LLC and Regenosis. Building on the strength of collaboration with National University of Singapore, this fresh investment accentuates RxCell’s resolute drive to revolutionize age-related disease treatment. “We’re thrilled to align with […]

Posted in BioUtah News | Comments Off on RxCell Announces $4.6M Investment from DMR Global Venture and Regenosis, Plans for Second Raise of $15M for IND Testing in Q4 2023

Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma

Culmination Bio has over 40 years of biospecimen data and counting, paired with clinical data from patient EHRs, making recruitment for pharmaceutical research almost instantaneous. St. George, Utah — (November 30, 2023) — Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health […]

Posted in BioUtah News | Comments Off on Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma

SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK – ENROLLMENT TO STOP DUE TO SUCCESS

SALT LAKE CITY, Dec. 6, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the Data Safety Monitoring Board (DSMB) overseeing its pivotal Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal […]

Posted in BioUtah News | Comments Off on SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK – ENROLLMENT TO STOP DUE TO SUCCESS

2023 Utah Life Sciences Summit Recap and Gallery

BioUtah yesterday held its 2023 Utah Life Sciences Summit, presented by Mayer Brown. Every year, the Summit is the largest gathering of Utah’s life sciences industry. This year was no exception. Following welcome remarks from Gov. Spencer Cox, a distinguished line-up of top executives addressed a packed house. Keynote speaker, Joseph Smith, chief scientific officer […]

Posted in BioUtah News | Comments Off on 2023 Utah Life Sciences Summit Recap and Gallery

2023 BioUtah Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit

SALT LAKE CITY – November 3, 2023 – BioUtah today announced the winners of its 2023 Life Sciences Awards. Five awards will be presented during the 2023 Mayer Brown Utah Life Sciences Summit Nov. 9 at the Salt Palace, in Salt Lake City. BioUtah’s annual awards recognize leaders, innovators and entrepreneurs who have made significant […]

Posted in BioUtah News | Comments Off on 2023 BioUtah Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit

ATL Announces New VP of Human Resources

Springville, Utah, October 27, 2023—ATL Technology, a dynamic and rapidly expanding company specializing in medical device development and manufacturing, is thrilled to introduce Danelle Goulet as the new Vice President of Human Resources. Expressing her enthusiasm for her new role, Danelle shared, “I am excited by the challenge of a fast-growing company in the medical […]

Posted in BioUtah News | Comments Off on ATL Announces New VP of Human Resources

BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J. (April 11, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with […]

Posted in BioUtah News | Comments Off on BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions